Petros Pharmaceuticals terminates Marcum as auditor, engages CBIZ; prior reports include going concern

Petros Pharmaceuticals, Inc.

Company terminated Marcum LLP as auditor on April 5, 2025, and engaged CBIZ CPAs P.C. as new independent auditor for FY 2025.
No disagreements or reportable events except a material weakness in internal controls over financial reporting disclosed in 2024 10-K.
Marcum's reports for FY 2023 and 2024 included an explanatory paragraph about substantial doubt as a going concern.
Marcum provided a letter to SEC dated April 9, 2025, agreeing with the company's statements (Exhibit 16.1 filed).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.